Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
41.99
-0.06 (-0.14%)
Mar 6, 2026, 10:18 AM EST - Market open
Xenon Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$53.70
Upside
+27.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $55 → $58 | Strong Buy | Maintains | $55 → $58 | +38.13% | Feb 27, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | +16.69% | Feb 27, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $60 | Buy | Initiates | $60 | +42.89% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +47.65% | Jan 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +14.31% | Dec 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +42.89% | Nov 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $58 | Buy | Maintains | $55 → $58 | +38.13% | Nov 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $48 → $44 | Buy | Maintains | $48 → $44 | +4.79% | Nov 4, 2025 |
| Needham | Needham | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +30.98% | Nov 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 | Strong Buy | Maintains | $55 | +30.98% | Oct 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $48 | Buy | Initiates | $48 | +14.31% | Sep 3, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +30.98% | Sep 2, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 | Strong Buy | Maintains | $55 | +30.98% | Aug 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $57 → $55 | Buy | Maintains | $57 → $55 | +30.98% | Aug 12, 2025 |
| Wedbush | Wedbush | Buy Maintains $42 → $43 | Buy | Maintains | $42 → $43 | +2.41% | Aug 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +35.75% | Jun 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.